Oncology Institute, Inc.TOIEarnings & Financial Report
Nasdaq · Health Care · Services-Offices & Clinics of Doctors of Medicine
Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| FMR LLC | 6.31% | 4.8M | — | 2023-07-10 |
| Havencrest Healthcare Partners, L.P. | 0.13% | 100.0K | ▼ -11.80pp | 2024-08-20 |
Insider Transactions
Net 90d: +$1.19M · buys $2.00M / sells $809.1KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-16 | Mohit Kaushal | Director | Sell (open market) | 38.4K | $3.50 | $134.5K |
| 2026-04-14 | Mohit Kaushal | Director | Sell (open market) | 57.3K | $3.50 | $200.6K |
| 2026-04-09 | Jorey Chernett | 10% Owner | Buy (open market) | 20.0K | $3.10 | $62.0K |
| 2026-03-27 | Carter Robert Ross | Chief Financial Officer | Grant | 202.9K | $0.00 | $0 |
| 2026-03-27 | Carter Robert Ross | Chief Financial Officer | Other | 20.3K | $3.07 | $62.4K |
| 2026-03-27 | Kristin England | Chief Administrative Officer | Grant | 55.7K | $0.00 | $0 |
| 2026-03-27 | Jeffrey Langsam | Chief Clinical Officer | Grant | 70.3K | $0.00 | $0 |
| 2026-03-27 | Yale Podnos | Chief Medical Officer | Grant | 66.4K | $0.00 | $0 |
| 2026-03-27 | Yale Podnos | Chief Medical Officer | Other | 16.2K | $3.07 | $49.7K |
| 2026-03-27 | Daniel Virnich | Chief Executive Officer | Grant | 670.6K | $0.00 | $0 |
1–10 of 21
Page 1 / 3